Why? There's man reasons. The company is dark, there's an extremely thin market for their shares, such that the spread is at 0.062/0.15, which is more than a 100% difference.
I picked up some shares last year around this time as they were being thrown out for tax losses @$0.05 and under.
I think cardiac PET is better than SPECT and the company announced last year they had made some sales, which caught my attention. I called the company and asked if they were tow seperate sales, as they curiously released the same generic PR on different dates (9/6/2018 to their website and 10/2/2018 to the newswire), their President told me that had made multiple sales in the past year after not making any since 2013, that there was a watershed moment in cardiac PET happening with newer studies and the scarcity of Tc-99 for SPECT at the time.
News 
Market Data 
Discover 
